Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Disc Medicine, Inc (IRON)  
$30.36 0.41 (1.33%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,140,000
Market Cap: 732.89(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.52 - $75.32
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gemeni Therapeutics is a clinical-stage precision medicine company developing therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). Co.'s lead product candidate, GEM103, is a recombinant form of the human complement factor H protein and is designed to address complement hyperactivity and overall dysregulation caused by loss of function mutations thus restoring retinal health in patients with AMD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 652,175
Total Buy Value $0 $0 $0 $15,000,025
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 3
Total Shares Sold 28,918 1,809,345 3,899,867 3,922,367
Total Sell Value $2,009,702 $108,295,610 $210,114,411 $210,161,436
Total People Sold 2 8 12 13
Total Sell Transactions 3 33 52 53
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 115
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Khara Rahul General Counsel   •       –      –    2023-11-03 4 AS $50.00 $5,000 D/D (100) 0 27%     
   Khara Rahul General Counsel   •       –      –    2023-11-03 4 OE $14.69 $1,469 D/D 100 100     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2023-09-16 4 S $53.22 $112,560 D/D (2,115) 1,593,785 -23%     
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2023-09-15 4 S $53.16 $13,869,125 D/D (260,894) 1,595,900 -19%     
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2023-09-14 4 S $53.05 $5,010,042 D/D (94,440) 1,856,794 -17%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-09-11 4 OE $9.86 $24,650 D/D 2,500 3,760     -
   Bryce Joanne Chief Financial Officer   •       –      –    2023-09-01 4 AS $52.99 $52,990 D/D (1,000) 1,260 18%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-09-01 4 OE $2.65 $2,650 D/D 1,000 2,260     -
   Savage William Jacob Chief Medical Officer   •       –      –    2023-08-21 4 OE $2.65 $7,950 D/D 3,000 3,000     -
   Bitterman Kevin Director   –       •      –    2023-08-15 4 S $52.40 $3,821,584 I/I (72,931) 882,224 -8%     
   Savage William Jacob Chief Medical Officer   •       –      –    2023-08-15 4 AS $52.27 $406,235 D/D (7,672) 0 8%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-08-15 4 S $52.40 $3,821,584 I/I (72,931) 882,224 -8%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-08-15 4 S $52.40 $5,820,016 D/D (111,069) 1,951,234 -8%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-08-14 4 S $52.00 $9,203,600 D/D (175,000) 2,062,303 -9%     
   Savage William Jacob Chief Medical Officer   •       –      –    2023-08-09 4 AS $48.90 $412,064 D/D (8,269) 7,672 17%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-08-01 4 AS $49.63 $225,633 D/D (4,521) 1,260 14%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-08-01 4 OE $1.01 $4,566 D/D 4,521 5,781     -
   Macdonald Brian Richard Chief Innovation Officer   •       –      –    2023-06-30 4 S $46.76 $28,058 D/D (600) 12,276 -11%     
   Macdonald Brian Richard Chief Innovation Officer   •       –      –    2023-06-30 4 AS $44.85 $194,778 D/D (4,324) 12,876 11%     
   Macdonald Brian Richard Chief Innovation Officer   •       –      –    2023-06-29 4 AS $44.37 $233,509 D/D (5,100) 17,200 2%     
   Savage William Jacob Chief Medical Officer   •       –      –    2023-06-28 4 AS $49.20 $219,114 D/D (4,384) 15,941 -5%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-06-28 4 AS $49.30 $503,114 D/D (10,072) 1,260 -5%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-06-28 4 OE $1.01 $7,959 D/D 7,880 11,332     -
   Macdonald Brian Richard Chief Innovation Officer   •       –      –    2023-06-28 4 AS $49.24 $254,795 D/D (5,100) 22,300 -5%     
   Novo A/s 10% Owner   –       –       •   2023-06-28 4 S $46.10 $57,625,000 D/D (1,250,000) 1,090,772 5%     
  115 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us